This website is intended for healthcare professionals

Sglt 2 inhibitors

Evidence-based use of newer agents in type 2 diabetes

Recent accumulating evidence on the use of newer therapies in type 2 diabetes (T2DM) is helping to define their position in treatment. This information coupled with the increasing priority given...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP